Non-Hodgkin's lymphoma in patients 70 years of age or older: Factors associated with survival

Leukemia Research

Volumn 26, Issue 5, 2002, Pages 447-450

  Cuttner, Janet ^a   Wallenstein, Sylvan ^a   Troy, Kevin ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Elderly; Non Hodgkin's lymphoma; Survival

Indexed keywords

DOXORUBICIN;

ACCURACY; AGED; ARTICLE; BONE MARROW CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; SURVIVAL RATE;

EID: 0036206784     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00163-1     Document Type: Article

References (9)

1. T cell activation in the elderly: Evidence for specific deficiencies in T cell/accessory cell interactions
2. Cancer incidence and survival of patients 65 years of age and older
3. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma
4. Age as a main prognostic factor in adult aggressive non-Hodgkin's lymphoma
5. International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma
6. Biology and physiology of aging
7. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence
8. Immunology of aging